Lanean...

Allogeneic hematopoietic cell transplantation for MDS: For whom, when and how?

Hematopoietic cell transplantation (HCT) is currently the only treatment with curative potential for patients with myelodysplastic syndrome (MDS). However, treatment-related mortality and relapse have remained major barriers to uniform success. Therefore, important questions remain to be answered, s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gyurkocza, Boglarka, Deeg, H. Joachim
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3509173/
https://ncbi.nlm.nih.gov/pubmed/22981712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2012.08.002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!